The GLP-1 tirzepatide, the active ingredient in Eli Lilly's Mounjaro, was found to reduce the risk of heart failure by 46% among individuals with obesity, according to a study published Nov. 16 in The New England Journal of Medicine and…
The Latest
Somerville, Mass.-based Mass General Brigham has appointed Patrick Ellinor, MD, PhD, as the inaugural executive director of the system's Heart and Vascular Institute.
Surgeons at Cincinnati-based The Christ Hospital performed a successful human implantation of the BiVACOR Total Artificial Heart, marking the fourth hospital in the U.S. to complete the procedure as part of the FDA's early feasibility study.
The FDA has warned providers of safety concerns and supply issues for Getinge/Maquet's VasoView HemoPro Endoscopic Vessel Harvesting Systems.
The FDA has warned providers of safety concerns and supply issues for Getinge/Maquet's VasoView HemoPro Endoscopic Vessel Harvesting Systems.
Naples, Fla.-based NCH Healthcare System continues to receive donations for the system's $265 million heart institute, expected to open in 2027.
Tyler, Texas-based Christus Mother Frances Hospital had the lowest unplanned readmission rate for coronary artery bypass graft surgery in the U.S. between July 1, 2020, and July 30, 2023, according to CMS data released Oct. 30.
Designed to temporarily prevent blood clots from traveling to the lungs, approximately 85% of inferior vena cava filters inserted over an eight-year period were not removed, according to a study published Nov. 6 in JAMA.
Between 1999 and 2020, obesity-related heart disease deaths in the U.S. increased by 180%, according to a preliminary study to be presented at the American Heart Association's annual Scientific Sessions, set for Nov. 16-18.
The American Heart Association and American Stroke Association recently published updated guidelines for the prevention of stroke. Some of the key updates include the utilization of GLP-1 medications and an emphasis on prevention of stroke in women.